Passage Bio, Inc.

NasdaqGS:PASG Voorraadrapport

Marktkapitalisatie: US$38.4m

Passage Bio Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Will Chou

Algemeen directeur

US$1.4m

Totale compensatie

Percentage CEO-salaris41.4%
Dienstverband CEO2.1yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.3yrs
Gemiddelde ambtstermijn bestuur3.6yrs

Recente managementupdates

Recent updates

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Sep 24
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Jun 11
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Feb 27
We're Keeping An Eye On Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Nov 13
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully

Jun 23
We Think Passage Bio (NASDAQ:PASG) Needs To Drive Business Growth Carefully

Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Nov 13
Is Passage Bio (NASDAQ:PASG) In A Good Position To Deliver On Growth Plans?

Passage appoints William Chou CEO

Oct 10

Passage Bio GAAP EPS of -$0.73 beats by $0.09

Aug 04

We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Jun 03
We're A Little Worried About Passage Bio's (NASDAQ:PASG) Cash Burn Rate

Passage Bio: Worth Keeping An Eye On

Apr 11

Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?

Dec 15
Will Passage Bio (NASDAQ:PASG) Spend Its Cash Wisely?

Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans

Aug 19
Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans

Passage Bio: Price Reduced, But Without Data, Does Not Look Convincing

Jun 06

Passage Bio partners with InformedDNA to offer counseling, testing for early dementia

May 03

We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely

Mar 08
We're Hopeful That Passage Bio (NASDAQ:PASG) Will Use Its Cash Wisely

Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?

Feb 01
Do Institutions Own Passage Bio, Inc. (NASDAQ:PASG) Shares?

Passage Bio on go with PBGM01 gene therapy trial in the U.S.

Jan 04

Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares

Dec 28
Need To Know: Passage Bio, Inc. (NASDAQ:PASG) Insiders Have Been Buying Shares

U.K. authorizes Passage Bio's PBGM01 trial

Dec 10

Passage Bio (PASG) Investor Presentation - Slideshow

Nov 16

Passage Bio EPS beats by $0.13

Nov 10

Passage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe disease

Oct 28

Analyse CEO-vergoeding

Hoe is Will Chou's beloning veranderd ten opzichte van Passage Bio's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$77m

Mar 31 2024n/an/a

-US$84m

Dec 31 2023US$1mUS$599k

-US$102m

Sep 30 2023n/an/a

-US$112m

Jun 30 2023n/an/a

-US$112m

Mar 31 2023n/an/a

-US$128m

Dec 31 2022US$1mUS$112k

-US$136m

Compensatie versus markt: De totale vergoeding ($USD 1.45M ) Will } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 653.16K ).

Compensatie versus inkomsten: De vergoeding van Will is gestegen terwijl het bedrijf verliesgevend is.


CEO

Will Chou (51 yo)

2.1yrs

Tenure

US$1,448,546

Compensatie

Dr. William Chou, MD, also known as Will, has been the Chief Executive Officer and Director of Passage Bio, Inc. from October 10, 2022 and serves as its President. Dr. Chou is an accomplished executive wit...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
William Chou
President2.1yrsUS$1.45mgeen gegevens
Edgar Cale
General Counsel & Company Secretary5.2yrsUS$804.69k0.080%
$ 30.7k
James Wilson
Co-Founder & Chief Scientific Advisorno datageen gegevensgeen gegevens
Kathleen Borthwick
Senior VP1.3yrsgeen gegevens0.046%
$ 17.7k
Stuart Henderson
Senior Vice President of Corporate Development & Investor Relations3.8yrsgeen gegevensgeen gegevens
Eden Fucci
Senior Vice President of Technical Operations1.3yrsgeen gegevensgeen gegevens
Sue Browne
Senior Vice President of Research & Developmentless than a yeargeen gegevensgeen gegevens
Karl Whitney
Senior Vice President of Global Regulatory Affairsless than a yeargeen gegevensgeen gegevens

1.3yrs

Gemiddelde duur

55.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van PASG wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
William Chou
President2.1yrsUS$1.45mgeen gegevens
Thomas Kassberg
Directorless than a yeargeen gegevensgeen gegevens
Maxine Gowen
Independent Chairwoman of the Board3.8yrsUS$101.34k0%
$ 0
Saqib Islam
Independent Director5.7yrsUS$65.84k0.0081%
$ 3.1k
Athena Countouriotis
Independent Director4.8yrsUS$69.97k0.031%
$ 11.7k
Sandip Kapadia
Independent Director4.9yrsUS$73.34k0%
$ 0
Derrell Porter
Independent Director3.5yrsUS$69.30k0%
$ 0
Dolan Sondhi
Independent Director1.3yrsUS$49.90k0%
$ 0

3.6yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PASG wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).